<!DOCTYPE html><html xml:lang="en" lang="en" xmlns="http://www.w3c.org/1999/xhtml">
  <head>
    <meta http-equiv="content-type" content="text/html; charset=utf-8" />
    <title>COT_H</title>
    <meta name="title" content="NHANES 2013-2014: Cotinine and Hydroxycotinine - Serum Data Documentation, Codebook, and Frequencies" />
    <link rel="stylesheet" href="https://wwwn.cdc.gov/nchs/nhanes/css/documentation.css" />
  </head>
  <body class="nhanes-doc">
    <div id="toc">
      <h3>Table of Contents</h3>
      <div id="toc-scroll">
        <ul>
          <li>
            <a href="#Component_Description">Component Description</a>
          </li>
          <li>
            <a href="#Eligible_Sample">Eligible Sample</a>
          </li>
          <li>
            <a href="#Description_of_Laboratory_Methodology">Description of Laboratory Methodology</a>
          </li>
          <li>
            <a href="#Laboratory_Method_Files">Laboratory Method Files</a>
          </li>
          <li>
            <a href="#Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</a>
          </li>
          <li>
            <a href="#Data_Processing_and_Editing">Data Processing and Editing</a>
          </li>
          <li>
            <a href="#Analytic_Notes">Analytic Notes</a>
          </li>
          <li>
            <a href="#References">References</a>
          </li>
          <li>
            <a href="#Codebook">Codebook</a>
            <ul id="CodebookLinks">
              <li>
                <a href="#SEQN">SEQN - Respondent sequence number</a>
              </li>
              <li>
                <a href="#LBXCOT">LBXCOT - Cotinine, Serum (ng/mL)</a>
              </li>
              <li>
                <a href="#LBDCOTLC">LBDCOTLC - Cotinine, Serum Comment Code</a>
              </li>
              <li>
                <a href="#LBXHCT">LBXHCT - Hydroxycotinine, Serum (ng/mL)</a>
              </li>
              <li>
                <a href="#LBDHCTLC">LBDHCTLC - Hydroxycotinine, Serum Comment Code</a>
              </li>
            </ul>
          </li>
        </ul>
      </div>
    </div>
    <div id="wrapper">
      <div id="PageHeader">
        <h1>National Health and Nutrition Examination Survey</h1>
        <h2>2013-2014 Data Documentation, Codebook, and Frequencies</h2>
        <h3>Cotinine and Hydroxycotinine - Serum (COT_H)</h3>
        <h4> Data File: COT_H.xpt</h4>
        <h5 class="left">First Published: October 2017</h5>
        <h5 class="right">Last Revised: NA</h5>
      </div>
      <div id="Sections">
        <h2 id="Component_Description">Component Description</h2><p><span style="font-family: Verdana;">The specific aims
of the component are: 1) to measure the prevalence and extent of tobacco use;
2) to estimate the extent of exposure to environmental tobacco smoke (ETS), and
determine trends in exposure to ETS; and 3) to describe the relationship
between tobacco use (as well as exposure to ETS) and chronic health conditions,
including respiratory and cardiovascular diseases.</span></p>
<p><span style="font-family: Verdana;">Cotinine and
trans-3&rsquo;-hydroxycotinine (hydroxycotinine) are the primary metabolites of
nicotine. The concentrations of cotinine and hydroxycotinine in body fluids can
be used as markers for active smoking and as indices for secondhand smoke (SHS)
exposure. Because their concentrations are greater and their elimination
half-lives significantly longer, these metabolites are generally preferred over
nicotine itself as biomarkers. Cotinine, the primary proximal metabolite of
nicotine, is generally regarded as the marker of choice. The estimated
elimination half-life of cotinine is about 15-20 hours; by contrast, the
half-life of nicotine is only 0.5-3 hours. The half-life of hydroxycotinine is
approximately 5-6 hours, but when hydroxycotinine is generated from cotinine,
its elimination half-life becomes similar to that of cotinine. </span></p>
<p><span style="font-family: Verdana;">Cotinine and
hydroxycotinine can be measured in serum, urine, and saliva?the half-life of
cotinine in all three fluids is essentially the same. Cotinine concentrations
tend to be three to eight times higher in urine than in serum; however, plasma
or serum is the fluid of choice for studies requiring a quantitative assessment
of exposure. For that reason, serum was chosen as the matrix for the National
Health and Nutrition Examination Survey (NHANES) cotinine analyses. In serum
hydroxycotinine concentrations tend to be two to four times lower than cotinine
concentrations.</span></p>
<p><span style="font-family: Verdana;">
The tobacco component for NHANES will include
questionnaire items on current and past use of cigarettes, pipes, cigars, and
smokeless tobacco. Questions will also be asked regarding exposure to ETS at
home, at work, and in utero among children. ETS exposure will also be assessed
for examinees 3 years of age and older, through the measurement of serum
cotinine, a metabolite of nicotine. In addition, use of nicotine replacement
products (e.g., gum and patch) will be collected, using questionnaires.<br />
</span></p><h2 id="Eligible_Sample">Eligible Sample</h2><p><span style="font-family: Verdana;">Examined
participants aged 3 years and older were eligible.</span></p><h2 id="Description_of_Laboratory_Methodology">Description of Laboratory Methodology</h2><p><span style="font-family: Verdana;">Serum cotinine
and hydroxycotinine are measured by an isotope-dilution high-performance liquid
chromatography/atmospheric pressure chemical ionization tandem mass
spectrometric (ID HPLC-APCI MS/MS) method. Briefly, the serum sample is spiked
with methyl-D3-cotinine and methyl-D3-hydroxycotinine as internal standards.
The sample is basified and then applied to a supported liquid extraction (SLE)
plate. The analytes are extracted with an isopropanol/methylene chloride
mixture, the organic extract is concentrated, and the residue is injected onto
a C18 HPLC column. The eluent from these injections is monitored by APCI-MS/MS.
The m/z 80 product ion from the m/z 177 quasi-molecular ion is measured for
cotinine and the m/z 80 product ion from the m/z 193 quasi-molecular ion is measured
for hydroxycotinine. Additional ions for the internal standards and for
confirmation are also monitored for the respective compounds. Analyte
concentrations are derived from the area ratios of native-to-labeled compounds
in the sample by comparisons to a standard curve.</span></p>
<p><span style="font-family: Verdana;">Refer to the
Laboratory Method Files section for a detailed description of of the laboratory
methods used. </span></p>
<p><span style="font-family: Verdana;">There was no
change in the lab site for this component in the NHANES 2013-2014 cycle.
However, there were changes to the method and equipment for this cycle. In the
2011-2012 cycle, the method was an entirely manual-based process, which
required 0.5 mL of serum and used Agilent ChemElut cartridges extraction media.
In the 2013-2014 cycle, an entirely automated process was introduced that requires
0.2 mL of serum, and uses Blotage Isolute SLE+ 96-well extraction plates for the
extraction media. Additionally, there was a change in lab equipment from the
SCIEX API 4000 Mass Spectrometer in the 2011-2012 cycle, to the SCIEX API 6500
Mass Spectrometer in the 2013-2014 cycle. All 2013-2014 NHANES specimens were
run with this new method and equipment. These changes are completely detailed
in the laboratory method file provided in the Laboratory Method Files section.
Please refer back to the method file in NHANES 2011-2012 cotinine dataset
(COTNAL_G) for more information about the previous method and equipment used.</span></p>
<p>
<br />
</p><h2 id="Laboratory_Method_Files">Laboratory Method Files</h2>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/public/2013/labmethods/COT_H_MET.pdf">Cotinine and Hydroxycotinine in Serum Laboratory Procedure Manual</a>
          <span> (October 2017)</span>
        </p>
        <h2 id="Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</h2><p><span style="font-family: Verdana;">Serum
specimens&nbsp;are processed, stored, and shipped to the Division of Laboratory
Sciences, National Center for Environmental Health, and Centers for Disease
Control and Prevention for analysis. </span></p>
<p><span style="font-family: Verdana;">Detailed
instructions on specimen collection and processing are discussed in the </span><a href="https://wwwn.cdc.gov/nchs/data/nhanes/2013-2014/manuals/2013_MEC_Laboratory_Procedures_Manual.pdf"><span style="color: #0a29a5; font-family: Verdana;">NHANES Laboratory
Procedures Manual (LPM)</span></a><span style="font-family: Verdana;">. Vials are stored under appropriate frozen (&ndash;20&deg;C)
conditions until they are shipped to National Center for Environmental Health
for testing.</span></p>
<p><span style="font-family: Verdana;">The NHANES
quality assurance and quality control (QA/QC) protocols meet the 1988 Clinical
Laboratory Improvement Act mandates. Detailed QA/QC instructions are discussed
in the&nbsp;</span><a href="https://wwwn.cdc.gov/nchs/data/nhanes/2013-2014/manuals/2013_MEC_Laboratory_Procedures_Manual.pdf"><span style="color: #0a29a5; font-family: Verdana;">NHANES LPM</span></a><span style="font-family: Verdana;">.</span></p>
<p><b style="mso-bidi-font-weight: normal;"><span style="font-family: Verdana;">Mobile Examination Centers (MECs)</span></b></p>
<p><span style="font-family: Verdana;">Laboratory team
performance is monitored using several techniques. NCHS and contract
consultants use a structured competency assessment evaluation during visits to
evaluate both the quality of the laboratory work and the quality-control
procedures. Each laboratory staff member is observed for equipment operation,
specimen collection and preparation; testing procedures and constructive feedback
are given to each staff member. Formal retraining sessions are conducted
annually to ensure that required skill levels were maintained. </span></p>
<p><b style="mso-bidi-font-weight: normal;"><span style="font-family: Verdana;">Analytical Laboratories </span></b></p>
<p><span style="font-family: Verdana;">NHANES uses
several methods to monitor the quality of the analyses performed by the contract
laboratories. In the MEC, these methods include performing blind split samples
collected on &ldquo;dry run&rdquo; sessions. In addition, contract laboratories randomly
perform repeat testing on 2% of all specimens.</span></p>
<p><span style="font-family: Verdana;">NCHS developed
and distributed a quality control protocol for all CDC and contract
laboratories which outlined the use of Westgard rules (Westgard et al., 1981)
when running NHANES specimens. Progress reports containing any problems
encountered during shipping or receipt of specimens, summary statistics for
each control pool, QC graphs, instrument calibration, reagents, and any special
considerations are submitted to NCHS quarterly. The reports are reviewed for
trends or shifts in the data. The laboratories are required to explain any
identified areas of concern.</span></p>
<p><span style="font-family: Verdana;">All QC procedures
recommended by the manufacturers were followed. Reported results for all assays
meet the Division of Laboratory Sciences quality control and quality assurance
performance criteria for accuracy and precision, similar to the Westgard rules
(Caudill, et al., 2008). </span></p><h2 id="Data_Processing_and_Editing">Data Processing and Editing</h2><p><span style="font-family: Verdana;">The data were
reviewed. Incomplete data or improbable values were sent to the performing
laboratory for confirmation.</span></p><h2 id="Analytic_Notes">Analytic Notes</h2><p><span style="font-family: Verdana;">Refer to the </span><a href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2013"><span style="color: #0a29a5; font-family: Verdana;">2013-2014 Laboratory Data
Overview</span></a><span style="font-family: Verdana;"> for
general information on NHANES laboratory data.</span></p>
<p><b style="mso-bidi-font-weight: normal;"><span style="font-family: Verdana;">Sample Weights</span></b></p>
<p><span style="font-family: Verdana;">Exam sample
weights should be used for analyses.</span></p>
<p><b style="mso-bidi-font-weight: normal;"><span style="font-family: Verdana;">Demographic and Other Related Variables</span></b></p>
<p><span style="font-family: Verdana;">The analysis of
NHANES laboratory data must be conducted using the appropriate survey design
and demographic variables. The </span><a href="https://wwwn.cdc.gov/Nchs/Nhanes/2013-2014/DEMO_H.htm"><span style="color: #0a29a5; font-family: Verdana;">NHANES 2013-2014 Demographics File</span></a><span style="font-family: Verdana;"> contains demographic
data, health indicators, and other related information collected during
household interviews as well as the sample weight variables. The recommended
procedure for variance estimation requires use of stratum and PSU variables
(SDMVSTRA and SDMVPSU, respectively) in the demographic data file. &nbsp;</span></p>
<p><span style="font-family: Verdana;">The </span><a href="https://wwwn.cdc.gov/Nchs/Nhanes/2013-2014/FASTQX_H.htm"><span style="color: #0a29a5; font-family: Verdana;">Fasting Questionnaire File</span></a><span style="font-family: Verdana;"> includes auxiliary
information such as fasting status, the length of fast, and the time of
venipuncture.</span></p>
<p><span style="font-family: Verdana;">The laboratory
data file can be linked to the other NHANES data files using the unique survey
participant identifier (i.e., SEQN).</span></p>
<p><b style="mso-bidi-font-weight: normal;"><span style="font-family: Verdana;">Detection Limits</span></b></p>
<p><span style="font-family: Verdana;">The detection
limits were constant for all of the analytes in the data set. Two variables are
provided for each of these analytes. The variable name ending in &ldquo;LC&rdquo; (ex.,
LBDCOTLC) indicates whether the result was below the limit of detection: the
value &ldquo;0&rdquo; means that the result was at or above the limit of detection, &ldquo;1&rdquo;
indicates that the result was below the limit of detection. For analytes with
analytic results below the lower limit of detection (ex. LBDCOTLC =1), an
imputed fill value was placed in the analyte results field. This value is the
lower limit of detection divided by the square root of 2 (LLOD/sqrt[2]). The
other variable prefixed LBD (ex., LBXCOT) provides the analytic result for the
analyte. </span></p>
<p><span style="font-family: Verdana;">The lower limit of
detection (LLOD in ng/mL) for Cotinine and Hydroxycotinine in serum is: </span></p>
<div style="text-align: center;">
<table style="border: currentColor; border-image: none; border-collapse: collapse; mso-table-layout-alt: fixed; mso-border-alt: solid black .75pt; mso-yfti-tbllook: 1184; mso-padding-alt: 1.5pt 1.5pt 1.5pt 1.5pt;" border="1" cellspacing="0" cellpadding="0">
    <thead>
        <tr style="height: 27.95pt; mso-yfti-irow: 0; mso-yfti-firstrow: yes;">
            <td style="background: #ddd9c3; padding: 3.75pt; border: 1pt solid black; border-image: none; width: 143.6pt; height: 27.95pt; mso-border-alt: solid black .75pt; mso-background-themecolor: background2; mso-background-themeshade: 230;">
            <p style="text-align: center;"><b><span style="font-family: Verdana;">VARIABLE</span></b></p>
            </td>
            <td style="background: #ddd9c3; border-width: 1pt 1pt 1pt 0px; border-style: solid solid solid none; border-color: black black black #000000; padding: 3.75pt; border-image: none; width: 213.25pt; height: 27.95pt; mso-border-alt: solid black .75pt; mso-background-themecolor: background2; mso-background-themeshade: 230; mso-border-left-alt: solid black .75pt;">
            <p style="text-align: center;"><b><span style="font-family: Verdana;">SAS
            LABEL</span></b></p>
            </td>
            <td style="background: #ddd9c3; border-width: 1pt 1pt 1pt 0px; border-style: solid solid solid none; border-color: black black black #000000; padding: 3.75pt; border-image: none; width: 106.1pt; height: 27.95pt; mso-border-alt: solid black .75pt; mso-background-themecolor: background2; mso-background-themeshade: 230; mso-border-left-alt: solid black .75pt;">
            <p style="text-align: center;"><b><span style="font-family: Verdana;">LLOD</span></b></p>
            </td>
        </tr>
    </thead>
    <tbody>
        <tr style="height: 27.95pt; mso-yfti-irow: 1;">
            <td style="border-width: 0px 1pt 1pt; border-style: none solid solid; border-color: #000000 black black; padding: 3.75pt; border-image: none; width: 143.6pt; height: 27.95pt; background-color: transparent; mso-border-alt: solid black .75pt; mso-border-top-alt: solid black .75pt;">
            <p style="text-align: center;"><span style="font-family: Verdana;">LBXCOT</span></p>
            </td>
            <td style="border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; border-color: #000000 black black #000000; padding: 3.75pt; width: 213.25pt; height: 27.95pt; background-color: transparent; mso-border-alt: solid black .75pt; mso-border-left-alt: solid black .75pt; mso-border-top-alt: solid black .75pt;">
            <p style="text-align: center;"><span style="font-family: Verdana;">Cotinine,
            serum</span></p>
            </td>
            <td style="border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; border-color: #000000 black black #000000; padding: 3.75pt; width: 106.1pt; height: 27.95pt; background-color: transparent; mso-border-alt: solid black .75pt; mso-border-left-alt: solid black .75pt; mso-border-top-alt: solid black .75pt;">
            <p style="text-align: center;"><span style="font-family: Verdana;">0.015</span></p>
            </td>
        </tr>
        <tr style="height: 27.95pt; mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
            <td style="border-width: 0px 1pt 1pt; border-style: none solid solid; border-color: #000000 black black; padding: 3.75pt; border-image: none; width: 143.6pt; height: 27.95pt; background-color: transparent; mso-border-alt: solid black .75pt; mso-border-top-alt: solid black .75pt;">
            <p style="text-align: center;"><span style="font-family: Verdana;">LBXHCT</span></p>
            </td>
            <td style="border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; border-color: #000000 black black #000000; padding: 3.75pt; width: 213.25pt; height: 27.95pt; background-color: transparent; mso-border-alt: solid black .75pt; mso-border-left-alt: solid black .75pt; mso-border-top-alt: solid black .75pt;">
            <p style="text-align: center;"><span style="font-family: Verdana;">Hydroxycotinine,
            serum</span></p>
            </td>
            <td style="border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; border-color: #000000 black black #000000; padding: 3.75pt; width: 106.1pt; height: 27.95pt; background-color: transparent; mso-border-alt: solid black .75pt; mso-border-left-alt: solid black .75pt; mso-border-top-alt: solid black .75pt;">
            <p style="text-align: center;"><span style="font-family: Verdana;">0.015</span></p>
            </td>
        </tr>
    </tbody>
</table>
</div>
<p><span style="font-family: Verdana;">&nbsp;</span></p>
<p><span style="font-family: Verdana;">Please refer to
the NHANES </span><a href="http://www.cdc.gov/nchs/nhanes/survey_methods.htm" target="_blank"><span style="color: #0a29a5; font-family: Verdana;">Analytic
Guidelines&nbsp;</span></a><span style="font-family: Verdana;">and the on-line NHANES&nbsp;</span><a href="http://www.cdc.gov/nchs/tutorials/" target="_blank"><span style="color: #0a29a5; font-family: Verdana;">Tutorial</span></a><span style="font-family: Verdana;"> for further details on the use of
sample weights and other analytic issues.</span></p></div>
      <div id="References">
        <h2>References</h2>
        <ul>
          <li>Caudill, S.P., Schleicher, R.L., Pirkle, J.L. Multi-rule quality control for the age-related eye disease study. Statist. Med. (2008) 27(20):4094-40106.</li>
          <li>Westgard J.O., Barry P.L., Hunt M.R., Groth T. A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem (1981) 27:493-501.</li>
        </ul>
      </div>
      <div id="Codebook">
        <h2>Codebook and Frequencies</h2>
        <div class="pagebreak">
          <h3 class="vartitle" id="SEQN">SEQN - Respondent sequence number</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SEQN</dd>
            <dt>SAS Label: </dt>
            <dd>Respondent sequence number</dd>
            <dt>English Text: </dt>
            <dd class="info">Respondent sequence number.</dd>
            <dt>Target: </dt>
            <dd> Both males and females 3 YEARS -
			150 YEARS</dd>
          </dl>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBXCOT">LBXCOT - Cotinine, Serum (ng/mL)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXCOT</dd>
            <dt>SAS Label: </dt>
            <dd>Cotinine, Serum (ng/mL)</dd>
            <dt>English Text: </dt>
            <dd class="info">Cotinine, Serum (ng/mL)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 3 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">0.011 to 1820</td>
                <td class="values">Range of Values</td>
                <td class="values" align="right">8029</td>
                <td class="values" align="right">8029</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">884</td>
                <td class="values" align="right">8913</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBDCOTLC">LBDCOTLC - Cotinine, Serum Comment Code</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBDCOTLC</dd>
            <dt>SAS Label: </dt>
            <dd>Cotinine, Serum Comment Code</dd>
            <dt>English Text: </dt>
            <dd class="info">Cotinine, Serum Comment Code</dd>
            <dt>Target: </dt>
            <dd> Both males and females 3 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">0</td>
                <td class="values">At or above the detection limit</td>
                <td class="values" align="right">5432</td>
                <td class="values" align="right">5432</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Below lower detection limit</td>
                <td class="values" align="right">2597</td>
                <td class="values" align="right">8029</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">Detectable result and exceeds the calibrated range of assay</td>
                <td class="values" align="right">0</td>
                <td class="values" align="right">8029</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">884</td>
                <td class="values" align="right">8913</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBXHCT">LBXHCT - Hydroxycotinine, Serum (ng/mL)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXHCT</dd>
            <dt>SAS Label: </dt>
            <dd>Hydroxycotinine, Serum (ng/mL)</dd>
            <dt>English Text: </dt>
            <dd class="info">Hydroxycotinine, Serum (ng/mL)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 3 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">0.011 to 1150</td>
                <td class="values">Range of Values</td>
                <td class="values" align="right">8029</td>
                <td class="values" align="right">8029</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">884</td>
                <td class="values" align="right">8913</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBDHCTLC">LBDHCTLC - Hydroxycotinine, Serum Comment Code</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBDHCTLC</dd>
            <dt>SAS Label: </dt>
            <dd>Hydroxycotinine, Serum Comment Code</dd>
            <dt>English Text: </dt>
            <dd class="info">Hydroxycotinine, Serum Comment Code</dd>
            <dt>Target: </dt>
            <dd> Both males and females 3 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">0</td>
                <td class="values">At or above detection limit</td>
                <td class="values" align="right">3820</td>
                <td class="values" align="right">3820</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Below lower detection limit</td>
                <td class="values" align="right">4209</td>
                <td class="values" align="right">8029</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">Detectable result and exceeds the calibrated range of assay</td>
                <td class="values" align="right">0</td>
                <td class="values" align="right">8029</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">884</td>
                <td class="values" align="right">8913</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
      </div>
    </div>
  </body>
</html>